You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

Financement des régimes fondés sur les données probantes

Les monographies et fiches d’information sur les médicaments et les régimes à l’intention des patients offrent des renseignements sur la posologie et l’administration des traitements contre le cancer.

Elles ne sont fournies qu’à titre indicatif et ne visent pas à remplacer les renseignements posologiques ni les recommandations d’un médecin.

Si vous avez des questions à propos du financement des TS-PBQ, veuillez consulter la Foire aux questions (anglais) de notre site Web.

Découvrez les fiches d’information améliorées sur les régimes à l’intention des patients, élaborées en collaboration avec les conseillers des patients et des familles. Disponible en français.

Regimens

Filtered By:
70 Items
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative
Drugs Used:
dexamethasone,
vinCRIStine,
methotrexate,
leucovorin,
pegaspargase (Unfunded),
cyclophosphamide,
etoposide
... Show more tags
Quick Link(s):
Regimen Monograph
Jun 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative
Drugs Used:
cytarabine,
dexamethasone,
methotrexate,
asparaginase,
vinCRIStine,
leucovorin
... Show more tags
Quick Link(s):
Regimen Monograph
Jun 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative
Drugs Used:
dexamethasone,
mercaptopurine,
methotrexate,
vinCRIStine,
leucovorin,
thioguanine,
cyclophosphamide,
etoposide,
cytarabine
... Show more tags
Quick Link(s):
Regimen Monograph
Jun 2019
Cancer Type: Hematologic, Leukemia - Acute Promyelocytic (APL)     
Intent: Curative
Drugs Used:
amsacrine,
cytarabine,
tretinoin (ATRA) (Unfunded)
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Hematologic, Leukemia - Acute Myeloid (AML)     
Intent: Curative
Drugs Used:
amsacrine,
cytarabine
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Hematologic, Lymphoma - T-cell     
Intent: Curative, Palliative
Drugs Used:
CISplatin,
etoposide,
ifosfamide,
mesna,
dexamethasone
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Genitourinary, Prostate     
Intent: Palliative
Funding:
New Drug Funding Program
    Denosumab - Hormone Refractory Prostate Cancer
Exceptional Access Program
    denosumab - Bony metastases in hormone refractory prostate cancer, with specific criteria
... Show more tags
Drugs Used:
denosumab
... Show more tags
Quick Link(s):
Regimen Monograph
Jul 2018
Cancer Type: Sarcoma, Giant Cell Tumour     
Intent: Curative
Drugs Used:
denosumab (Unfunded)
... Show more tags
Quick Link(s):
Regimen Monograph
Jul 2018
Cancer Type: Breast, Genitourinary, Renal cell / Kidney, Lung, Mesothelioma, Non-Small Cell, Small Cell, Unknown Primary     
Intent: Palliative
Drugs Used:
denosumab (Unfunded)
... Show more tags
Quick Link(s):
Regimen Monograph
Jul 2018
Cancer Type: Hematologic, Multiple Myeloma     
Intent: Palliative
Drugs Used:
denosumab (Unfunded)
... Show more tags
Quick Link(s):
Regimen Monograph
Oct 2018
Cancer Type: Sarcoma, Soft Tissue     
Intent: Neoadjuvant, Adjuvant, Palliative
Drugs Used:
DOXOrubicin,
ifosfamide,
mesna
... Show more tags
Quick Link(s):
Regimen Monograph
Apr 2016
Cancer Type: Gynecologic, Uterine Sarcoma, Sarcoma, Uterine     
Intent: Palliative
Drugs Used:
DOXOrubicin,
ifosfamide,
mesna
... Show more tags
Quick Link(s):
Regimen Monograph
Nov 2017